Advertisement

Issues

Advertisement

Error loading Partial View script (file: ~/Views/MacroPartials/TAP List All Issues.cshtml)

Advertisement

Advertisement



Jan
23
Today In Oncology
Detecting GI Tumors Using a Cell-Free DNA Test
Young Adults With Colorectal Cancer Living in Areas of Low Income, Education Likely to Have Worse Survival Outcomes
Patient-Reported Outcomes From IMbrave150, BEACON CRC
JAVELIN Bladder 100 Study of Avelumab for Urothelial Cancer Meets Primary Endpoint
Overall Survival With the Addition of Daratumumab to VMP in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
View More 
Advertisement
Most Read Stories
Relevance of the Hippocratic Oath in the 21st Century
Treatment Resistance and Novel Therapies in FGFR-Mutated Cholangiocarcinoma
Different Doses of Adjuvant Ipilimumab vs High-Dose Interferon Alfa-2b in Patients With Resected High-Risk Melanoma
Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes
Maintenance Bevacizumab With or Without Pemetrexed in Advanced Nonsquamous NSCLC
View More 
Most Viewed Videos
Luis G. Paz-Ares, MD, PhD, on Small Cell Lung Cancer: Efficacy and Safety of Lurbinectedin
Jeff P. Sharman, MD, on CLL: Trial Results on Acalabrutinib, Obinutuzumab, and Chlorambucil
Catherine M. Diefenbach, MD, on Follicular Lymphoma: Polatuzumab Vedotin Plus Obinutuzumab/Lenalidomide
Nicoletta Colombo, MD, on Lenvatinib/Pembrolizumab for Advanced Endometrial Cancer
Paolo A. Ascierto, MD, on Melanoma: Results From CheckMate 238 on Adjuvant Nivolumab vs Ipilimumab
View More 
© 2020 HSP News Service, L.L.C.